[Form 4] Rigetti Computing, Inc. Warrants Insider Trading Activity
Thomas J. Iannotti, a director of Rigetti Computing, Inc., reported option exercise and share sales executed under a Rule 10b5-1 plan. On 08/14/2025 he exercised a stock option at an exercise price of $1.17 for 100,000 shares and sold 100,000 shares in multiple transactions at a weighted-average price of $16.6987 (prices ranged $16.58–$16.76). Following these transactions the filing reports 14,902 shares of common stock directly beneficially owned and 620,000 derivative securities (options) held directly. The 10b5-1 trading plan was adopted May 15, 2025. The option vesting schedule noted that one-third vested November 15, 2024, with remaining portions vesting in two equal annual installments thereafter.
- Transaction executed under a Rule 10b5-1 trading plan, indicating a pre-established compliance mechanism
- Exercise price was $1.17, materially below sale price, allowing the reporting person to realize substantial proceeds
- Filing discloses weighted-average sale price and range, increasing transparency about the disposition
- Director sold 100,000 shares, reducing direct common stock holdings to 14,902 shares
- Large portion of economic interest remains in unexercised options (620,000), which may create ongoing incentive alignment and potential dilution
Insights
TL;DR: Director exercised low-strike options and sold an equal number of shares under a 10b5-1 plan, realizing substantial proceeds.
The filing shows a routine insider liquidity event: exercise of 100,000 options at $1.17 and immediate disposition of 100,000 shares at ~ $16.70 weighted average. This realizes meaningful pre-tax spread per share versus the strike and reduces the director's direct common stock holding to 14,902 shares while leaving substantial unexercised options (620,000). The use of a 10b5-1 plan provides procedural compliance and reduces timing concerns around the sale.
TL;DR: The trade was conducted under an adopted 10b5-1 plan and was executed by an attorney-in-fact, reflecting formal compliance steps.
The document discloses the 10b5-1 plan adoption date (May 15, 2025) and the signature by an attorney-in-fact, indicating administrative oversight. The disclosure includes the weighted-average sale price range and the vesting timetable for the exercised option. These elements align with standard insider disclosure practices and satisfy transparency expectations for director transactions.